Dr Kirsty Crowe
- Clinical Research Fellow (Cardiovascular & Metabolic Health)
email:
Kirsty.Crowe@glasgow.ac.uk
pronouns:
She/her/hers
The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
email:
Kirsty.Crowe@glasgow.ac.uk
pronouns:
She/her/hers
Stoumpos, S., Crowe, K., Sarafidis, P., Barratt, J., Bolignano, D., Del Vecchio, L., Małyszko, J., Więcek, A., Ortiz, A. and Cozzolino, M. (2024) Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in chronic kidney disease: a document by the European Renal Best Practice board of the European Renal Association. Nephrology Dialysis Transplantation, (doi: 10.1093/ndt/gfae075) (PMID:38573822) (In Press)
Crowe, K., Quinn, T. J. , Mark, P. B. and Findlay, M. D. (2021) “Is it removed during dialysis?”—cognitive dysfunction in advanced kidney failure—a review article. Frontiers in Neurology, 12, 787370. (doi: 10.3389/fneur.2021.787370)
Stoumpos, S., Crowe, K., Sarafidis, P., Barratt, J., Bolignano, D., Del Vecchio, L., Małyszko, J., Więcek, A., Ortiz, A. and Cozzolino, M. (2024) Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in chronic kidney disease: a document by the European Renal Best Practice board of the European Renal Association. Nephrology Dialysis Transplantation, (doi: 10.1093/ndt/gfae075) (PMID:38573822) (In Press)
Crowe, K., Quinn, T. J. , Mark, P. B. and Findlay, M. D. (2021) “Is it removed during dialysis?”—cognitive dysfunction in advanced kidney failure—a review article. Frontiers in Neurology, 12, 787370. (doi: 10.3389/fneur.2021.787370)